|
MedPage Today OB/Gyn
|
OB/Gyn Headlines
|
-
New Bevacizumab Data Fails to Support Use in Advanced Breast CA
WASHINGTON (MedPage Today) -- Adding bevacizumab (Avastin) to chemotherapy drugs doesn't increase survival or improve symptoms for women with advanced breast cancer, according to FDA documents posted in advance of an advisory panel meeting on Tuesday.
-
Off-Hour Births Carry Higher Risk of Perinatal Death (CME/CE)
Giving birth outside the typical 9-to-5 workday (MedPage Today) -- as most women do -- was associated with a greater chance of the baby dying within the first four weeks of life, a British study showed.
-
Top Choice for Breast CA Is Aromatase Inhibitor (CME/CE)
Aromatase inhibitor therapy should be considered for all postmenopausal women with hormone receptor-positive breast cancers, the American Society of Clinical Oncology re-emphasized.
-
Community-Based Program Promising for Weight Control (CME/CE)
Women with young children appear to have achieved better weight control over the course of a year after participating in a community-based behavioral intervention program, researchers reported.
-
Weight Loss May Help Hot Flushes (CME/CE)
Overweight postmenopausal women had significant improvement in hot flushes with an intensive behavioral weight-loss program, data from a randomized trial showed.
-
Fish Oil Linked to Lower Breast CA Risk (CME/CE)
Fish oil could help prevent breast cancer, according to observational findings linking the supplements to lower breast cancer risk.
-
Tapering Favored for Stopping Hormones After Menopause (CME/CE)
For postmenopausal women who discontinue hormone therapy (HT), tapering treatment appears overwhelmingly favored over a sharp halt, researchers found.
-
Colon Cancer Screening Improves but Not Enough (CME/CE)
ATLANTA (MedPage Today) -- Universal screening for colorectal cancer could prevent 32,000 deaths a year -- but not enough people are being screened, according to a study of recent trends in screening for colon and breast cancer.
|
|
